Effective Treatment of NSCLC with Surgery After Nivolumab Combined with Chemotherapy: A Case Report and Brief Review of the Literature

INTRODUCTION: Immuno checkpoint inhibitors (ICIs) including anti-PD-L1 antibody have shown certain therapeutic effects on various cancer types. Here, we reported a case of the patient with resectable non-small cell lung cancer (NSCLC) showing a complete response to nivolumab combined with chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Liangchen, Li, Luzhen, Chen, Ting, Fang, Cantu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779284/
https://www.ncbi.nlm.nih.gov/pubmed/33408481
http://dx.doi.org/10.2147/OTT.S266155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779284/
https://www.ncbi.nlm.nih.gov/pubmed/33408481
http://dx.doi.org/10.2147/OTT.S266155

Ejemplares similares